Search Results - Martin, Emmett T., MPH

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Innovation in resuscitation: A novel clinical decision display system for advanced cardiac life support

    Innovation in resuscitation: A novel clinical decision display system for advanced cardiac life support by Crabb, David B., MD, Hurwitz, Joshua E., MS, Reed, Austin C., MD, Smith, Zachary J, Martin, Emmett T., MPH, Tyndall, J. Adrian, MD, MPH, Taasan, Michael V., MPH, Plourde, Michelle A., MSN, Beattie, Lars K., MD, MS

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Overall survival with [ 177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    Overall survival with [ 177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 tr... by Hofman, Michael S, Prof, Emmett, Louise, Prof, Sandhu, Shahneen, MBBS, Iravani, Amir, MD, Buteau, James P, MD, Joshua, Anthony M, Prof, Goh, Jeffrey C, Prof, Pattison, David A, MBBS, Tan, Thean Hsiang, MBBS, Kirkwood, Ian D, MBBS, Ng, Siobhan, MBBS, Francis, Roslyn J, PhD, Gedye, Craig, PhD, Rutherford, Natalie K, MD, Weickhardt, Andrew, PhD, Scott, Andrew M, Prof, Lee, Sze-Ting, PhD, Kwan, Edmond M, PhD, Azad, Arun A, PhD, Ramdave, Shakher, MD, Redfern, Andrew D, MBChB, Macdonald, William, MPH, Guminski, Alex, PhD, Hsiao, Edward, MBChB, Chua, Wei, PhD, Lin, Peter, MBBS, Zhang, Alison Yan, PhD, Stockler, Martin R, Prof, Williams, Scott G, Prof, Martin, Andrew J, Prof, Davis, Ian D, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Overall survival and quality of life with [ 177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial

    Overall survival and quality of life with [ 177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary out... by Emmett, Louise, Prof, Subramaniam, Shalini, MBBS, Crumbaker, Megan, PhD, Joshua, Anthony M, Prof, Sandhu, Shahneen, Prof, Nguyen, Andrew, MBBS, Weickhardt, Andrew, PhD, Lee, Sze-Ting, Prof, Ng, Siobhan, MBBS, Francis, Roslyn J, PhD, Goh, Jeffrey C, Prof, Pattison, David A, MBBS, Tan, Thean Hsiang, MBBS, Kirkwood, Ian D, MBBS, Gedye, Craig, PhD, Rutherford, Natalie K, MD, Kumar, Aravind S Ravi, MBBS, Pook, David, MD, Ramdave, Shakher, MD, Nadebaum, David P, MBBS, Voskoboynik, Mark, MBBS, Redfern, Andrew D, MBChB, Macdonald, William, MPH, Krieger, Laurence, MBChB, Schembri, Geoff, MBChB, Chua, Wei, PhD, Lin, Peter, MBBS, Horvath, Lisa, Prof, Bastick, Patricia, MBBS, Butler, Patrick, MD, Zhang, Alison Yan, PhD, McJannett, Margaret, RN, Thomas, Hayley, MBiostat, Langford, Ailsa, BSc, Hofman, Michael S, Prof, Martin, Andrew James, Prof, Davis, Ian D, Prof, Stockler, Martin R, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: